InnovationVolitionRx demonstrated quantification of nucleosomes in whole venous blood in minutes using a lateral flow device, showcasing early detection of immune disruptions.
PartnershipsThe anticipated announcement of a partnership in the human health space is seen as the most important catalyst, potentially providing non-dilutive capital and validating the business strategy.
Revenue GrowthRevenue grew 44% in 1Q25, with licensing deals expected to boost financial performance.